NCT00547664 - Efficacy of Hylenex in the Treatment of Pain Among Hospice Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

October 31, 2010

Conditions

Pain Management

Interventions

DRUG

Hylenex recombinant , morphine, saline

Subcutaneous infusion of morphine and hydromorphone (Dilaudid) with or without the preceded co-injection of Hylenex. Hospice patients include both home-bound patients as well as those under intensive care in hospice houses.

OTHER

Saline

Subcutaneous infusion of morphine and hydromorphone (Dilaudid) with the preceded co-injection of saline.

Trial Locations (3)

33609

LifePath Hospice, Inc., Tampa

33637

HPC Healthcare, Inc., Temple Terrace

33815

Good Shepherd Hospice, Lakeland